Evidence map›Paper›PMID 39578485›Full record

ArticleNature communications2024

ClickGen: Directed exploration of synthesizable chemical space via modular reactions and reinforcement learning.

Mingyang Wang, Shuai Li, Jike Wang, Odin Zhang, Hongyan Du, Dejun Jiang, Zhenxing Wu, Yafeng Deng, Yu Kang, Peichen Pan and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Ultrafast Formation of Aza-Quinone Methides from Suitably SubstitutedJournal of the American Chemical Society · 2026
    Article
  6. Experimental and Mechanistic Validation of PARP1pred for Identifying Potent Leads.Computational and structural biotechnology journal · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Generative AI for navigating synthesizable chemical space.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Generative Deep Learning for de Novo Drug Design─A Chemical Space Odyssey.Journal of chemical information and modeling · 2025
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Mingyang Wang *College of Pharmaceutical Sciences and Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.ORCID 0009-0001-2779-5769
Shuai Li *Institute of Traditional Chinese Medicine, Chengde Medical University, Chengde, 067000, Hebei, China.
Jike Wang *College of Pharmaceutical Sciences and Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Odin ZhangCollege of Pharmaceutical Sciences and Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Hongyan DuCollege of Pharmaceutical Sciences and Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Dejun JiangCollege of Pharmaceutical Sciences and Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Zhenxing WuCollege of Pharmaceutical Sciences and Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.ORCID 0000-0002-1060-5957
Yafeng DengInstitute of Traditional Chinese Medicine, Chengde Medical University, Chengde, 067000, Hebei, China.
Yu KangCollege of Pharmaceutical Sciences and Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.ORCID 0000-0002-0999-8802
Peichen PanCollege of Pharmaceutical Sciences and Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.ORCID 0000-0003-1152-7759
Dan LiCollege of Pharmaceutical Sciences and Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China.
Xiaorui WangDr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Macao, 999078, China.ORCID 0000-0001-6893-2013
Xiaojun YaoFaculty of Applied Sciences, Macao Polytechnic University, Macao, 999078, China.
Tingjun HouCollege of Pharmaceutical Sciences and Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China. tingjunhou@zju.edu.cn.ORCID 0000-0001-7227-2580
Chang-Yu HsiehCollege of Pharmaceutical Sciences and Cancer Center, Zhejiang University, Hangzhou, 310058, Zhejiang, China. kimhsieh@zju.edu.cn.ORCID 0000-0002-6242-4218

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22373085
6 · The paper itself

Abstract

Despite the significant potential of generative models, low synthesizability of many generated molecules limits their real-world applications. In response to this issue, we develop ClickGen, a deep learning model that utilizes modular reactions like click chemistry to assemble molecules and incorporates reinforcement learning along with inpainting technique to ensure that the proposed molecules display high diversity, novelty and strong binding tendency. ClickGen demonstrates superior performance over the other reaction-based generative models in terms of novelty, synthesizability, and docking conformation similarity for existing binders targeting the three proteins. We then proceeded to conduct wet-lab validation on the ClickGen's proposed molecules for poly adenosine diphosphate-ribose polymerase 1. Due to the guaranteed high synthesizability and model-generated synthetic routes for reference, we successfully produced and tested the bioactivity of these novel compounds in just 20 days, much faster than typically expected time frame when handling sufficiently novel molecules. In bioactivity assays, two lead compounds demonstrated superior anti-proliferative efficacy against cancer cell lines, low toxicity, and nanomolar-level inhibitory activity to PARP1. We demonstrate that ClickGen and related models may represent a new paradigm in molecular generation, bringing AI-driven, automated experimentation and closed-loop molecular design closer to realization.

Indexed as

Click ChemistryDeep LearningAntineoplastic AgentsCell Line, TumorCell ProliferationHumansMolecular Docking SimulationPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase InhibitorsAntineoplastic AgentsPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase Inhibitors

Identifiers

PMID39578485
PMCPMC11584676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.